{"issuance_frequency":"","notes_translated":{"fr":"Les décisions prises concernant les vaccins contre la COVID-19 suivront les processus établis pour les examens dans les exigences relatives aux médicaments contre la COVID-19. Santé Canada amorcera des examens continus afin de constituer un dossier complet pour chaque vaccin. Le dossier comprendra des données à l'appui de l'innocuité, de l'efficacité et de la qualité du vaccin proposé.","en":"Decisions made about COVID-19 vaccines will follow processes established for reviews under the modified requirements for COVID-19 drugs. Health Canada will start rolling reviews to build towards a complete dossier for each vaccine. The dossier will include data to support the safety, efficacy and quality of the proposed vaccine."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"703993ef-f60c-453e-8df8-d140590781cd","metadata_created":"2021-07-29T12:12:24.006126","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-07-29T12:12:24.006133","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-07-29","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["coronavirus","COVID-19","pandémie","médicaments","médicaments","vaccins","autorisation de mise sur le marché","licence","importation ou vente","vaccin COVID-19","processus d'examen","transparence"],"en":["coronavirus","COVID-19","pandemic","drugs","medications","vaccines","market authorization","licensing","importing or selling","COVID-19 vaccine","review process","transparency"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Lignes directrices sur les exigences relatives aux autorisations de mise en marché des vaccins contre la COVID-19 : Processus d’examen, communications et transparence","en":"Guidance for market authorization requirements for COVID-19 vaccines: Review process, communications and transparency"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"703993ef-f60c-453e-8df8-d140590781cd","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"981edce2-6787-473d-8caa-b4c8f35a75ae","related_relationship":"","name_translated":{"fr":"Lignes directrices sur les exigences relatives aux autorisations de mise en marché des vaccins contre la COVID-19 : Processus d’examen, communications et transparence","en":"Guidance for market authorization requirements for COVID-19 vaccines: Review process, communications and transparency"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance for market authorization requirements for COVID-19 vaccines: Review process, communications and transparency","language":["en"],"created":"2021-07-29T12:12:24.083190","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/guidance-market-authorization-vaccines/review-process-communications-transparency.html","last_modified":null,"position":0,"revision_id":"e33bb77e-2c2d-41e4-bd02-cab219803878","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"703993ef-f60c-453e-8df8-d140590781cd","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"624abad7-179d-4f53-9fe6-0dd3aa819fb2","related_relationship":"","name_translated":{"fr":"Lignes directrices sur les exigences relatives aux autorisations de mise en marché des vaccins contre la COVID-19 : Processus d’examen, communications et transparence","en":"Guidance for market authorization requirements for COVID-19 vaccines: Review process, communications and transparency"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance for market authorization requirements for COVID-19 vaccines: Review process, communications and transparency","language":["fr"],"created":"2021-07-29T12:12:24.083196","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/ligne-directrices-autorisations-mise-marche-vaccins/processus-examen-communications-transparence.html","last_modified":null,"position":1,"revision_id":"e33bb77e-2c2d-41e4-bd02-cab219803878","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2021-03-26 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"703993ef-f60c-453e-8df8-d140590781cd","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"Decisions made about COVID-19 vaccines will follow processes established for reviews under the modified requirements for COVID-19 drugs. Health Canada will start rolling reviews to build towards a complete dossier for each vaccine. The dossier will include data to support the safety, efficacy and quality of the proposed vaccine.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Guidance for market authorization requirements for COVID-19 vaccines: Review process, communications and transparency","revision_id":"e33bb77e-2c2d-41e4-bd02-cab219803878"}